Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Hainan Huluwa Pharmaceutical Group Co., Ltd.
Address
No. 8, Yaogu 4th Road
Haikou, 570300
China
Phone
86 898 6868 9766
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2103
First IPO Date
July 10, 2020
Key Executives
| Name | Title | Pay | Year Born |
| Hui Yu | Financial Director, Deputy GM & Director | 0 | 1984 |
| Jinping Liu | GM & Chairman of the Board | 0 | 1970 |
| Pei Hu Li | Deputy General Manager | 0 | 1973 |
| Tianbao Wei | Deputy General Manager | 0 | 1967 |
| Qingtao Wang | Secretary | 0 | 1982 |
| Jun Ling Li | Deputy GM & Director | 0 | 1968 |
| Wei Li | Accounting Supervisor | 0 | N/A |
AD
Description
Hainan Huluwa Pharmaceutical Group Co., Ltd. is a pharmaceutical company that undertakes the development, production, and commercialization of medicines. Their principal focus lies in the field of pediatric healthcare, specifically addressing respiratory and digestive system ailments in children across China. A prominent product in their portfolio is a 4-gram dosage of lung heat cough medication for children, offered in both granule and capsule forms. Established in 2005, the company's operations are headquartered in Haikou, China.
AD
